DHANZIA
Live / Registered — Registered (as of 06 Jan 2026)
What this means for you
Registered since 06 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99090661
- Registration number
- 8092517
- Mark type
- Stylized text
- Filed
- 18 Mar 2025
- Published for opposition
- 18 Nov 2025
- Registered
- 06 Jan 2026
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: anti-inflammatories; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiac diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune-mediated diseases and disorders; pharmaceutical preparations for the prevention and treatment of rare genetic diseases and disorders
Owner
- Kiniksa Pharmaceuticals, GmbH, Zug, CH
- Kiniksa Pharmaceuticals, GmbH, Zug, CH
- Kiniksa Pharmaceuticals, GmbH, Zug, CH
Prosecution history
- 06 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Oct 2025 — EXAMINER'S AMENDMENT ENTERED
- 22 Oct 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 Oct 2025 — EXAMINERS AMENDMENT E-MAILED
- 22 Oct 2025 — EXAMINERS AMENDMENT -WRITTEN
- 14 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 14 Oct 2025 — FINAL REFUSAL E-MAILED
- 14 Oct 2025 — FINAL REFUSAL WRITTEN
- 14 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE